30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q14 Revenue: Implanet

€1,188MM (~US $1,509.35MM), -28%

  • Spine/JAZZ Platform ~$499.31MM, +109%
  • Knee + Arthroscopy ~$1,010.05MM, -26%
    • Knee ~$793.3MM, +69%
    • Arthroscopy ~$195.2MM, -78%


  • Continuing to phase out hip product sales
  • Arthroscopy decline due to holding of an implant order due to subcontractor delay; products will deliver and bill in 4Q
  • 989 JAZZ implants sold (+215%), >150 procedures performed